L-Carnitine Oral (500mg)

$48.89

QuantityDiscountPrice
5 - 85%$46.45
9+10%$44.00
FOR LABORATORY RESEARCH USE ONLY.
NOT FOR HUMAN OR ANIMAL CONSUMPTION.
NOT FOR MEDICAL, DIAGNOSTIC, OR VETERINARY USE.

Free shipping on orders over $200!

  • Check Mark Satisfaction Guaranteed
  • Check Mark No Hassle Refunds
  • Check Mark Secure Payments
  • Visa Card
  • MasterCard
  • American Express
  • Discover Card
  • PayPal
  • Apple Pay
GUARANTEED SAFE CHECKOUT
SKU: IN0041 Category:

L-Carnitine Oral Peptide

L-Carnitine (β-hydroxy-γ-trimethylaminobutyric acid) is an endogenous quaternary ammonium compound synthesized primarily in the liver and kidneys from lysine and methionine. It plays an essential role in mitochondrial fatty-acid transport, enabling long-chain fatty acids to enter the mitochondrial matrix for β-oxidation, thereby regulating cellular energy balance.

In experimental biology, L-Carnitine is widely used as a tool compound to investigate mitochondrial metabolism, oxidative stress modulation, lipid handling, muscle energetics, neuroprotection, and metabolic disease pathways.


Specifications

Synonyms: L-3-Hydroxy-4-(trimethylammonio)butanoate, Levocarnitine
Molecular formula: C₇H₁₅NO₃
Molecular weight: 161.20 g/mol
Class: Mitochondrial fatty-acid transport facilitator / metabolic modulator


Mechanism of Action and Mitochondrial Fatty-Acid Transport

L-Carnitine is required for the carnitine shuttle, a system composed of:

  • Carnitine palmitoyltransferase I (CPT1)

  • Carnitine-acylcarnitine translocase (CACT)

  • Carnitine palmitoyltransferase II (CPT2)

Through this pathway, L-Carnitine:

  • Transfers long-chain acyl groups across the inner mitochondrial membrane

  • Supports β-oxidation and ATP generation

  • Maintains free CoA availability, preventing accumulation of acyl-CoA and metabolic stress

Research has shown that supplemental L-Carnitine can:

  • Increase mitochondrial oxidative capacity

  • Reduce intracellular acyl-CoA accumulation

  • Enhance fatty-acid flux in hepatocytes and skeletal muscle

A mechanistic review by Longo et al. highlights how the carnitine system integrates with overall mitochondrial function, redox control, and metabolic resilience.


L-Carnitine, Glucose Homeostasis and Insulin Sensitivity

Experimental models have demonstrated significant metabolic effects:

Skeletal muscle insulin sensitivity

  • Mingrone et al. showed that L-Carnitine infusion increased glucose disposal rates by improving skeletal-muscle oxidation and reducing intramyocellular lipid content—key drivers of insulin resistance.

  • Wall et al. reported enhanced muscle glycogen synthesis and improved insulin-mediated glucose uptake in controlled metabolic studies.

Hepatic glucose metabolism

Research indicates that L-Carnitine:

  • Reduces hepatic lipid accumulation

  • Improves mitochondrial β-oxidation

  • Lowers gluconeogenesis markers in animal models of metabolic dysfunction

These effects make L-Carnitine a valuable tool for dissecting pathways linking lipid metabolism, mitochondrial overload, and insulin signaling.


Cardiovascular and Ischemia–Reperfusion Research

L-Carnitine has been extensively studied in cardiac metabolic physiology due to the heart’s strong dependence on fatty-acid oxidation.

Myocardial ischemia–reperfusion

  • Arsenian et al. demonstrated improved left-ventricular function and reduced arrhythmias in dog models receiving L-Carnitine during reperfusion.

  • Research by Calabrese et al. found reduced myocardial infarct size and improved antioxidant status, including lower lipid peroxidation and higher GSH/GSSG ratios.

Cardiac metabolism

Experimental findings indicate that L-Carnitine:

  • Stabilizes mitochondrial membranes

  • Enhances recovery of ATP and phosphocreatine levels

  • Mitigates accumulation of toxic acyl compounds during ischemia

These outcomes support L-Carnitine’s use as a research probe for mitochondrial cardioprotection, energetic recovery, and ischemic stress biology.


L-Carnitine in Muscle Physiology, Performance, and Recovery

L-Carnitine is widely used in skeletal-muscle studies due to its influence on mitochondrial fatty-acid oxidation and oxygen utilization.

Exercise metabolism

  • Broad et al. documented improved post-exercise lactate clearance and enhanced markers of mitochondrial function.

  • Volek et al. observed reduced exercise-induced muscle damage, decreased myoglobin release, and improved recovery kinetics.

Mitochondrial adaptations

Research shows that L-Carnitine can:

  • Increase expression of genes involved in oxidative metabolism

  • Enhance mitochondrial biogenesis via PGC-1α activation

  • Modulate reactive oxygen species (ROS) during prolonged muscle activity

Due to these findings, L-Carnitine remains an essential compound for exploring metabolic adaptations to endurance, overload training, and muscle damage models.


Neuroprotection, Oxidative Stress, and Mitochondrial Health

L-Carnitine and its acetylated form (acetyl-L-carnitine) have been widely studied in neuronal and mitochondrial-stress models.

Neuronal energy and survival

  • Virmani et al. reported improved mitochondrial respiration and reduced oxidative damage in neuronal cultures exposed to metabolic stress.

  • Experimental rat models showed reduced apoptosis and improved memory performance following L-Carnitine administration.

Mitochondrial dynamics and ROS

Studies indicate that L-Carnitine can:

  • Improve mitochondrial membrane stability

  • Decrease lipid peroxidation markers

  • Upregulate antioxidant enzymes including SOD and catalase

  • Modulate acetyl-CoA/CoA balance, improving neuronal metabolic flexibility

These observations highlight L-Carnitine’s value in research exploring neurodegeneration, oxidative injury, and mitochondrial dysfunction.


Inflammation, Organ Injury and Immune-Metabolic Crosstalk

Recent research has evaluated L-Carnitine in acute and chronic inflammatory models:

Sepsis and systemic inflammation

  • Gam et al. demonstrated reduced TNF-α and IL-6 release in LPS-stimulated macrophages treated with L-Carnitine.

  • In rodent sepsis models, L-Carnitine reduced multi-organ injury markers and improved survival in controlled experimental settings.

Liver injury and metabolic inflammation

Experimental findings include:

  • Lower hepatic steatosis

  • Reduced oxidative stress (lower MDA levels)

  • Improved mitochondrial β-oxidation and ATP output

L-Carnitine is therefore widely used to probe the interplay between mitochondrial metabolism and inflammatory signaling.


Other Experimental Applications

Lipid metabolism:
Modulates plasma triglycerides and acyl-carnitine profiles in hepatic models.

Aging research:
Improves mitochondrial protein acetylation, reduces oxidative damage, and enhances energetic output in models of aging muscle and brain.

Endocrine research:
Interacts with thyroid-hormone–regulated metabolic pathways and may influence thermogenesis in brown adipose tissue models.


Research Use Only – Important Notice

This L-Carnitine product is supplied exclusively for laboratory research purposes.

  • Not for human or veterinary use

  • Not for diagnostic, therapeutic, or cosmetic applications

  • Intended only for in vitro experiments or controlled animal studies by qualified professionals

  • All descriptions summarize findings from preclinical and mechanistic studies

  • Not to be interpreted as medical claims or guidance for self-administration


References

(Only peer-reviewed scientific sources — no Wikipedia)

  1. Longo N. et al. Carnitine and fatty acid oxidation. Molecular Genetics and Metabolism (2006).
    https://www.sciencedirect.com/science/article/pii/S1096719206000028

2. Mingrone G. et al. L-Carnitine infusion improves glucose disposal and insulin sensitivity in type 2 diabetes. American Journal of Clinical Nutrition (1999).
https://academic.oup.com/ajcn/article/69/5/914/4729138

3. Wall B.T. et al. L-Carnitine and skeletal muscle glucose metabolism in humans. Journal of Physiology (2011).
https://physoc.onlinelibrary.wiley.com/doi/full/10.1113/jphysiol.2011.208637

4. Arsenian M.A. Potential cardioprotective effects of L-Carnitine in ischemic heart failure models. Circulation (1997).
https://www.ahajournals.org/doi/10.1161/01.CIR.95.3.780

5. Calabrese V. et al. Carnitine and antioxidant systems in ischemia–reperfusion injury. International Journal of Molecular Medicine (2005).
https://www.spandidos-publications.com/10.3892/ijmm.15.6.965

6. Broad E.M. et al. L-Carnitine supplementation and exercise metabolism. International Journal of Sport Nutrition and Exercise Metabolism (2008).
https://journals.humankinetics.com/view/journals/ijsnem/18/4/article-p376.xml

7. Volek J.S. et al. L-Carnitine reduces markers of muscle damage following exercise. Nutrition (2002).
https://www.sciencedirect.com/science/article/pii/S0899900701007333

8. Virmani A. et al. L-Carnitine and mitochondrial dysfunction in the brain: oxidative stress models. Annals of the New York Academy of Sciences (2002).
https://nyaspubs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1749-6632.2002.tb04879.x

10. Gam S. et al. Anti-inflammatory effects of L-Carnitine in macrophages. Nutrition Research (2019).
https://www.sciencedirect.com/science/article/pii/S0271531719300100

11. Malaguarnera M. et al. Carnitine in inflammation and liver disease models. Current Pharmaceutical Design (2012).
https://pubmed.ncbi.nlm.nih.gov/22236120/